Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Stock
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
22.3M
-
Shares change
-
+22.3M
-
Total reported value, excl. options
-
$152M
-
Value change
-
+$152M
-
Put/Call ratio
-
0.11
-
Number of buys
-
81
-
Price
-
$6.84
Significant Holders of VYNE THERAPEUTICS INC COM - Stock (VYNE) as of Q1 2021
85 filings reported holding VYNE - VYNE THERAPEUTICS INC COM - Stock as of Q1 2021.
VYNE THERAPEUTICS INC COM - Stock (VYNE) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.3M shares
.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (6.77M shares), BlackRock Inc. (3.61M shares), VANGUARD GROUP INC (2.49M shares), FRANKLIN RESOURCES INC (1.69M shares), DSC Advisors, L.P. (1.04M shares), STATE STREET CORP (959K shares), AXA S.A. (882K shares), GEODE CAPITAL MANAGEMENT, LLC (730K shares), DELTEC ASSET MANAGEMENT LLC (441K shares), and Healthcare Value Capital, LLC (400K shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.